Therneau TM - Search Results

1

Daclizumab induction therapy in liver transplant recipients with renal insufficiency.

Asrani SK, Kim WR, Pedersen RA, Charlton MR, Kremers WK, Therneau TM, Rosen CB, Dean PG. Asrani SK, et al. Among authors: therneau tm. Aliment Pharmacol Ther. 2010 Sep;32(6):776-86. doi: 10.1111/j.1365-2036.2010.04408.x. Epub 2010 Jul 26. Aliment Pharmacol Ther. 2010. PMID: 20659283 Free PMC article.

2

Preoperative predictors of resource utilization in liver transplantation.

Kim WR, Therneau TM, Dickson ER, Evans RW. Kim WR, et al. Among authors: therneau tm. Clin Transpl. 1995:315-22. Clin Transpl. 1995. PMID: 8794277

3

Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C.

Kim WR, Poterucha JJ, Hermans JE, Therneau TM, Dickson ER, Evans RW, Gross JB Jr. Kim WR, et al. Among authors: therneau tm. Ann Intern Med. 1997 Nov 15;127(10):866-74. doi: 10.7326/0003-4819-127-10-199711150-00002. Ann Intern Med. 1997. PMID: 9382364

4

Optimal timing of liver transplantation for primary biliary cirrhosis.

Kim WR, Wiesner RH, Therneau TM, Poterucha JJ, Porayko MK, Evans RW, Klintmalm GB, Crippin JS, Krom RA, Dickson ER. Kim WR, et al. Among authors: therneau tm. Hepatology. 1998 Jul;28(1):33-8. doi: 10.1002/hep.510280106. Hepatology. 1998. PMID: 9657093

5

TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis.

Charlton M, Adjei P, Poterucha J, Zein N, Moore B, Therneau T, Krom R, Wiesner R. Charlton M, et al. Hepatology. 1998 Sep;28(3):839-42. doi: 10.1002/hep.510280335. Hepatology. 1998. PMID: 9731581

6

Quality of life before and after liver transplantation for cholestatic liver disease.

Gross CR, Malinchoc M, Kim WR, Evans RW, Wiesner RH, Petz JL, Crippin JS, Klintmalm GB, Levy MF, Ricci P, Therneau TM, Dickson ER. Gross CR, et al. Among authors: therneau tm. Hepatology. 1999 Feb;29(2):356-64. doi: 10.1002/hep.510290229. Hepatology. 1999. PMID: 9918910

7

The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.

Kim WR, Poterucha JJ, Wiesner RH, LaRusso NF, Lindor KD, Petz J, Therneau TM, Malinchoc M, Dickson ER. Kim WR, et al. Among authors: therneau tm. Hepatology. 1999 Jun;29(6):1643-8. doi: 10.1002/hep.510290607. Hepatology. 1999. PMID: 10347102

8

Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization.

Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Malinchoc M, Benson JT, Crippin JS, Klintmalm GB, Rakela J, Starzl TE, Krom RA, Evans RW, Dickson ER. Kim WR, et al. Among authors: therneau tm. Hepatology. 1999 Aug;30(2):395-400. doi: 10.1002/hep.510300210. Hepatology. 1999. PMID: 10421646 Free PMC article.

9

Clinical significance of TT virus infection in patients with chronic hepatitis C.

Zein NN, Arslan M, Li H, Charlton MR, Gross JB Jr, Poterucha JJ, Therneau TM, Kolbert CP, Persing DH. Zein NN, et al. Among authors: therneau tm. Am J Gastroenterol. 1999 Oct;94(10):3020-7. doi: 10.1111/j.1572-0241.1999.01457.x. Am J Gastroenterol. 1999. PMID: 10520863

10

Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers.

Cleavinger PJ, Persing DH, Li H, Moore SB, Charlton MR, Sievers C, Therneau TM, Zein NN. Cleavinger PJ, et al. Among authors: therneau tm. Am J Gastroenterol. 2000 Mar;95(3):772-6. doi: 10.1111/j.1572-0241.2000.01820.x. Am J Gastroenterol. 2000. PMID: 10710073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters